MedTrace Logo

Sleep and Pain in Sickle Cell Disease

NCT03150433 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 57

Last updated 2025-01-24

No results posted yet for this study

Summary

This is a study testing the effects of behavioral sleep interventions on pain and brain function in sickle cell disease.

Conditions

Interventions

BEHAVIORAL

Behavioral symptom management

Individual sessions focused on behavioral and cognitive strategies for managing sleep disturbance, pain, and other symptoms of sickle cell disease

OTHER

Sickle cell disease management

Individual sessions focused on understanding and managing sickle cell disease

Sponsors & Collaborators

  • University of Maryland

    collaborator OTHER

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • Johns Hopkins University

    lead OTHER

Principal Investigators

  • Claudia Campbell, PhD · Johns Hopkins University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-05
Primary Completion
2023-06-30
Completion
2023-10-27

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03150433 on ClinicalTrials.gov